Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Ethical Drug Market Up 4.8% in 3rd Qtr; Aricept Surges
December 10, 2007
- Alliances with Overseas Facilities Considered
December 10, 2007
- Astellas to Acquire Agensys Inc.
December 10, 2007
- Takepron Replaces Gaster as No.1 Drug for Ulcers
December 10, 2007
- R&D NEWS IN BRIEF
December 10, 2007
- BUSINESS NEWS IN BRIEF
December 10, 2007
- Nichi-Iko to Prepare Action Program to Enhance Reliability of Generics
December 10, 2007
- NEW PRODUCTS／Mochida: Beselna Cream 5%
December 10, 2007
- JMA Accepts New Prescription Form If Box Is Provided for Each Drug
December 10, 2007
- TOPICS／ACCJ Demands Participation of Foreign-Affiliated Companies in Informatization Process
December 10, 2007
- Pharmacists Must Play More Active Role in Promoting Use of Generics
December 10, 2007
- Industry Opposed to Re-Pricing of a Wider Range of Drugs
December 10, 2007
- JGPMA Accepted as Full Member of IGPA
December 10, 2007
- Another Reduction in Medical Fees Non Recommendable: Chuikyo
December 10, 2007
- Kobashou's Shareholders Approve Share Exchange with Mediceo
December 10, 2007
- Market Price Survey Shows Average Price Gap of 6.5%
December 10, 2007
- Taisho: Switch OTC Drug Containing Ambroxol Approved
December 10, 2007
- Janssen's Prezista Included in NHI Price List
December 10, 2007
- NEW PRODUCTS／SSP to Launch S.TAC EVE FINE
December 10, 2007
- Partial Changes in Approval for Xeloda, Taxol Recommended
December 10, 2007
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…